About the Editors
Joining the Editorial Board
If you are interested in joining the BJC Reports team as an Editorial Board Member or Associate Editor, please complete this Google form. Associate Editors are part of the editorial team that handle manuscripts, while Editorial Board Members are regular reviewers and are consulted for ad hoc advice. We will contact you if your expertise meets the needs of the journal.
Editor-in-Chief
Marc Tischkowitz, MD, PhD, is a Professor of Medical Genetics and Honorary Consultant in the Department of Medical Genetics at Cambridge. He completed his medical degree in 1993 and trained in Medical Oncology before completing his CCST in Medical Genetics. From 1999-2002 he undertook a PhD researching the role of Fanconi anemia gene mutations in the development of sporadic acute myeloid leukaemia. He held a Consultant post at Great Ormond Street Hospital before moving to McGill University, Montreal in 2005 where he worked on Faculty for six years before coming to Cambridge. Much of his research has been on the Fanconi Anemia genes and hereditary breast cancer predisposition but his interests cover all areas of hereditary cancer and translating the recent advances in genomic technology into clinical practice.
Deputy Editor
Seamus O'Reilly, MD, PhD, is a consultant medical oncologist at Cork Mercy and South Infirmary Victoria University Hospitals. A graduate of University College Galway, he completed medical oncology training at Johns Hopkins Hospital, Baltimore, MD where he was subsequently Assistant Professor in Medical Oncology. During fellowship training there he completed a PhD in Clinical Investigation and focused on Cancer Pharmacology in his research. He is vice clinical lead at Cancer Trials Ireland, a founding trustee and co-Chairperson of Cork ARC Cancer Support House and was National Specialty Director in Medical Oncology at the Royal College of Physicians from 2013-2021. Prof. O'Reilly is an active investigator in cancer trials at Cork University Hospital (CUH) with an emphasis on breast and gynaecologic cancers and is Principal Investigator of a Phase I trial of Lithium as an autophagy enhancer with chemotherapy for gastrointestinal cancers.
Subject Editor
GENETICS & GENOMICS
Sachin Katyal, PhD, University of Manitoba, Canada
Interests: DNA damage and repair, brain tumours, lymphoproliferative disease, chronic lymphocytic leukemia, treatment resistance, novel cancer chemotherapeutics, neurodegeneration
Associate Editors
CELLULAR & MOLECULAR BIOLOGY
Armita Bahrami, MD, Emory University, USA
Interests: Sarcoma, bone and soft tissue tumors, cancer pathology, genomics of mesenchymal tumors, molecular diagnostics in cancer, cancer/sarcoma pathogenesis
Arun Dharmarajan, PhD, Curtin University and The University of Western Australia, Australia; Sriramachandra Institute of Higher Education and Research, India
Interests: Wnt signalling, secreted frizzled related protein-4 (sFRP4), cancer stem cells, epigenetics, nanotechnology, mesencymal stem cells, tumour angiogenesis
Sunny Das, PhD, Whitehead Institute for Biomedical Research, USA
Interests: Metastasis, EMT, epigenetics, immunology, ER+ breast cancer
Morten Frier Gjerstorff, PhD, University of Southern Denmark
Interests: Tumor antigens, tumor microenvironment, targeted therapy, epigenetic drugs, melanoma, breast cancer
Jerome Devy, PhD, UMR CNRS/URCA 7369 MEDYC (Extracellular Matrix and Cellular Dynamic), Reims, France
Interests: Extracellular matrix, LRP-1, breast cancer, tumor microenvironment
Kevin Dzobo, PhD, University of Cape Town, South Africa
Interests: Breast cancer, cancer stem cells, mesenchymal stem cells, drug resistance, regenerative medicine, tissue engineering, biomaterials
Interests: Antibody-based therapeutics, small molecule-based therapeutics, brain cancer, blood cancer, liver cancer, treatment resistance, transcription factors, helicases, Burkitt’s lymphoma, diffuse large B cell lymphoma, anti-cancer compounds 
Simona Gurzu, MD, PhD, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu-Mures, Romania
Interests: Colorectal cancer, gastric cancer, hepatocellular carcinoma, pancreatic cancer, neuroendocrine tumors, familial cancer, histogenesis, histopathology, immunohistochemistry, epithelial-mesenchymal transition, molecular diagnostic, biomarkers, targeted therapy
Kentaro Inamura, MD, PhD, The Cancer Institute, Japanese Foundation for Cancer Research, Japan
Interests: Tumor microbiome, tumor microenvironment, pathology
Jesang Ko, PhD, Korea University, South Korea
Interests: Transcriptional regulation, cancer metabolism, extracellular vesicles, tumor microenvironment, EMT, prostate cancer
Interests: Molecular pathways, therapeutic targets, brain tumors, cancer stem cells
Interests: Cancer epigenetics, histone modifications, DNA damage repair, genome stability, epigenetic inheritance, DNA replication
Tugba Bagci Onder, PhD, Koç University, Turkey
Interests: Molecular mechanisms of therapeutic resistance, epigenetic basis of drug response, apoptosis, CRISPR-based focused library development and loss-of-function screens, localized delivery of anti-cancer therapeutics
Biswarup Saha, PhD, H. Lee Moffitt Cancer Center & Research Institute, USA
Interests: Lung cancer, pancreatic cancer, KRAS signaling, cancer stem cells, tumor biology, tumor metastasis, EMT, desmoplasia, ECM, tumor microenvironment, epigenetics, post-translational modification(s), drug resistance, biochemistry, cell signaling mechanisms
CLINICAL STUDIES
Mikkel Bandak, MD, Rigshospitalet, Denmark
Interests: Genitourinary cancers (especially testicular cancer), clinical studies, trial design, patient involvement 
Khalid El Bairi, MD, Mohammed VI Polytechnic University, Morocco
Interests: Ovarian cancer, research integrity issues in oncology
Christina Fotopoulou, MD, PhD, Imperial College London, UK
Interests: Ovarian cancer, surgery, cytoreduction, survival, endometrial cancer
Ana Ferrigno Guajardo, MD, Yale School of Medicine, USA
Interests: Breast cancer, patient-reported outcomes, health care disparities, end-of-life care, survivorship
Nagi Kumar, PhD, Moffitt Cancer Center, USA
Interests: Breast cancer, chemoprevention, biomarkers, epidemiology, risk mitigation
Pierfrancesco Lapolla, MD, University of Oxford, UK
Interests: Surgery, colorectal cancer, minimally invasive surgery, surgical oncology, laparoscopic surgery, rectal cancer, anastomosis techniques, enhanced recovery after surgery (ERAS), neoadjuvant therapy, vascular surgery, surgical complications, pancreaticoduodenectomy, distal pancreatectomy, Whipple procedure, pancreatic cancer
Wayne Nicholls, MB ChB, DCH, University of Queensland, Australia
Interests: Sarcoma (0-30 year olds), neuroblastoma (any age), brain tumours (paediatric and adolescent), immunotherapy, cancer predisposition syndromes, clinical trials (cooperative group and pharma trials)
Masaki Shiota, MD, PhD, Kyushu University, Japan
Interests: Prostate cancer, androgen receptor, drug resistance, metastasis, genetics, genomics
Mangesh Thorat, MBBS, MS(Surgery), DNB(Surgery), PhD, Kings College London, UK
Interests: Breast cancer (DCIS, biomarkers, cancer prevention), clinical trials, (cancer prevention), drug repurposing (cancer prevention focus), cancer epidemiology, breast surgery/surgical oncology
Giuseppe Vizzielli, MD, PhD, University of Udine, Italy
Interests: Ovarian cancer; endometrial carcinoma, cervical carcinoma, surgery, gynecological malignancies
Ke Zhao, PhD, Guangdong Provincial People's Hospital, China
Interests: Digital pathology, artificial intelligence, colorectal cancer, cancer imaging, radiology
EPIDEMIOLOGY
Jennifer Brooks, PhD, University of Toronto, Canada
Interests: Breast cancer, genetics, risk prediction, screening, imaging, survivorship
Subhayan Chattopadhyay, PhD, Lund University, Sweden
Interests: Evolutionary oncology, mathematical oncology, theoretical biology, genetic epidemiology
Susan Jordan, PhD, The University of Queensland, Australia
Interests: Gynaecological cancer, thyroid cancer, risk factors, clinical pathways, survival, large scale linkage of administrative data
Carlijn M. van der Aalst, PhD, MPH, Erasmus MC – University Medical Centre Rotterdam, The Netherlands
Interests: (Lung) cancer screening, clinical trials, health behavioural change/quality of life, cancer epidemiology, health care disparities 
Matty P. Weijenberg, PhD, Maastricht University, The Netherlands
Interests: Colorectal cancer, etiology, cancer survivors, risk factors, lifestyle, diet, nutrition, supplements, physical activity, sedentary behaviour, sleep, body composition, body weight, overweight, quality of life, fatigue, peripheral neuropathy, molecular subtypes of cancer, genetic variation, metabolomics, kynurenines, inflammation
GENETICS & GENOMICS
Jeremy Chien, PhD, University of California, Davis, USA
Interests: Ovarian cancer, genomics, therapy resistance, functional genomics, TP53-targeted therapies, cancer cell plasticity, unfolded protein response, proteostasis
Adam Karpf, PhD, University of Nebraska Medical Center, USAInterests: Ovarian cancer, molecular therapeutics, transcription factors, epigenetics, DNA methylation, DNA replication stress
Alexey Larionov, PhD, Cranfield University, UK
Interests: Cancer bioinformatics, genetic predisposition to breast cancer, hormonal and targeted treatment of breast cancer
Youngsoo Lee, PhD, Ajou University School of Medicine, South Korea
Interests: DNA damage response, chromatin remodeling, DNA epigenetic modification, genomic instability, brain tumor, brain development
Rengyun Liu, PhD, Sun Yat-sen University, China
Interests: Cancer genetics, DNA methylation, telomerase, MAPK pathway, targeted therapy, thyroid cancer
Paola Marcato, PhD, Dalhousie University, Canada
Interests: Breast cancer, metastasis, drug resistance, epigenetics, long non-coding RNA, cancer stem cells, immunotherapy
Anello Marcello Poma, PhD, University of Pisa, Italy
Interests: Molecular pathology, cancer biomarkers, thyroid cancer, cancer genetics, transcriptomics, biostatistics
Amit Roshan, PhD, Cambridge University, UK
Interests: Melanoma, surgical oncology, early detection, stem cells, liquid biopsies, circulating tumour DNA, cancer genomics
Mikio Shimada, PhD, Tokyo Institute of Technology, Japan
Keywords: DNA repair, DNA replication, centrosome, genome instability, neurodegeneration, tissue organoid
Chengwu Zeng, PhD, Jinan University, China
TRANSLATIONAL THERAPEUTICS
Line Bjørge, MD, PhD, University of Bergen, NorwayInterests: Gynaecological oncology, tumor microenvironment, resistance, targeted therapy, 3D models, animal models
Raelene Endersby, PhD, Telethon Kids Cancer Centre, Australia
Clare Hoskins, PhD, University of Strathclyde, UKInterests: Pancreatic cancer, cancer nanomedicine, targeted delivery, precision medicine
Christopher Jones, MBChB, PhD, Cambridge University, UKInterests: Upper gastrointestinal cancers, radiotherapy, radiobiology, systemic anti-cancer treatments, cell and molecular biology
Banafshé Larijani, PhD, University of Bath, Centre for Therapeutic Innovation, UKInterests: Cell biophysics, cancer signaling pathways, quantitative molecular imaging & spectroscopy, immuno-oncology, phosphoinositide signaling
Karl Payne, BDS, PhD, Institute of Cancer and Genomic Sciences, University of Birmingham, UKInterests: Head and neck cancer, liquid biopsy, biomarker discovery, circulating tumour cells, circulating tumour DNA, microvascular surgical reconstruction, facial surgery
Yi-Chen Zhang, MD, Guangdong Lung Cancer Institute, Southern Medical University, China
Interests: Resistance mechanisms to targeted therapy, lung cancer immunotherapy, strategies to overcome resistance, hereditary susceptibility of lung cancer
Editorial Board
CELLULAR & MOLECULAR BIOLOGY
Chiara Ambrogio, PhD, University of Torino, Italy
Interests: KRAS biology, MAPK signaling, resistance to therapy, lung cancer biology, early tumorigenesis, genetically engineered mouse models
Crispin Hiley, PhD, University College London, UK
Interests: Radiation oncology, lung cancer, stereotactic radiotherapy, metastatic cancers, chemotherapy, immunotherapy, radiotherapy
Neha Kausik, PhD, University of Suwon, South Korea
Interests: Cancer prognostic markers, translational oncology, cancer metastasis and relapse, drug delivery systems, cancer genomics
Stephanie Kermorgant, PhD, Barts Cancer Insitute, QMUL, UK
Interests: Receptor, signalling, endocytosis, cell migration, metastasis
Emmanuelle Liaudet-Coopman, PhD, INSERM, Montpellier, France
Interests: Breast cancer, protease, tumor microenvironment, antibody-based therapy, immunotherapy
Sharon Prince, PhD, University of Cape Town, South Africa
Interests: Anti-cancer drug targets, breast cancer, cervical cancer, pancreatic cancer, sarcoma, TBX2, TBX3
Abeer Shaaban, PhD, University of Birmingham, UK
Interests: Breast cancer, predictive and prognostic markers, tumour micro environment, companion diagnostics
Yashwanth Subbannayya, PhD, University of Surrey, UK
Interests: Systems biology, proteomics, cancer biology, tumor immunology
Sherine Xueqin Sun, PhD, Cold Spring Harbor Laboratory, USA
Interests: Genetics, epigenetics, brain tumor, chromatin regulator, chromatin remodeling, signaling pathway
CLINICAL STUDIES
Shivani Bailey, MBBS, BSc, Birmingham Children’s Hospital, UK
Interests: Paediatric brain tumours, early phase clinical trials, patient reported outcomes in paediatric oncology, relapsed/refractory solid and brain tumours in paediatric oncology
Elizabeth Brem, MD, University of California, Irvine, USA
Interests: Hematologic malignancies, clinical trials, translational research, lymphoma, CLL, non-hodgkin lymphoma, BCL2 family
Megan Delisle, MD, University of Manitoba, Canada
Interests: Precision oncology, clinical trials, implementation science, colorectal cancer, melanoma
Sara Lightowlers, MB BChir, University of Cambridge, UK
Interests: Breast cancer, radiotherapy, clinical trials, healthcare sustainability
Filipe Correia Martins, MD, PhD, Cambridge University, UK
Interests: Gynecologic oncology, ovarian cancer, surgery
Grainne O'Kane, MB BCh BAO, Trinity St James’s Cancer Institute, IrelandInterests: Pancreatic cancer, hepatobiliary cancers, early phase clinical trials, biomarker-driven clinical trial design, integrative molecular profiling of tumours
Timothy A. Yap, MD, PhD, MD Anderson, USAInterests: Phase I, DNA Damage Response
GENETICS & GENOMICS
Raymond Kim, MD/PhD, Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; Hospital for Sick Children, Canada
Interests: Hereditary cancer syndromes, medical genetics, cancer early detection, liquid biopsy
Evgeny Imyanitov, PhD, N.N. Petrov Institute of Oncology; St. Petersburg Pediatric Medical University, Russia
Interests: Translational oncology, hereditary cancer syndromes, predictive markers
Valentina Silvestri, PhD, Sapienza University of Rome, Italy
Interests: Breast cancer, genetic susceptibility, BRCA genes, cancer risk assessment, polygenic risk scores, molecular biomarkers
Bente Talseth-Palmer, PhD, University of Newcastle, Australia
Interests: Colorectal cancer, genetics, genomics, inherited gastroenterology cancer, Lynch Syndrome/HNPCC, familial adenomatous polyposis (FAP)
Jun Yang, PhD, St. Jude Children's Research Hospital, USA
Interests: Hypoxia, epigenetics, splicing, cancer signaling, genetic cancer models, combination therapy, drug discovery, pediatric cancers
George Zogopoulos, MD, PhD, McGill University Health Centre; Rosalind and Morris Goodman Cancer Institute, Canada
Interests: Pancreaticobiliary surgical oncology, genetics, oncogenomics, transplant oncology
MOLECULAR DIAGNOSTICS
Brigitte Bauvois, PhD, Sorbonne University, France
Interests: Leukemia, cancer biomarkers
Rashmi Rana, PhD, Sir Ganga Ram Hospital, India
Interests: Cancer therapy, translational research, diagnostic biomarkers, meningioma, glioma, metastasis
TRANSLATIONAL THERAPEUTICS
Rohidas Arote, PhD, Seoul National University, South Korea
Interests: Gene therapy, biomaterials, nanomedicine, drug discovery, drug delivery
Sanjib Chaudhary, PhD, Indian Institute of Technology, Guwahati, India
Interests: Molecular therapeutics, cancer stem cells, therapy resistance, transcriptomics, molecular biology
Yingchun Zeng, PhD, Hangzhou City University, China
Interests: Lung cancer, cervical cancer, cancer rehabilitation, artificial intelligence
